AERO vs EXPO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a remarkably low P/E of 0.48 suggesting deep value, this is likely due to negative earnings or accounting distortions, as evidenced by the negative Price/Book ratio of -4.06, which signals shareholder equity deficiency. Revenue and earnings are contracting sharply year-over-year, with earnings down 50%, while operating cash flow and balance sheet metrics are unavailable, raising transparency concerns. Analysts recommend a 'buy' with a $29.73 target, implying 41% upside, but this contrasts with deteriorating fundamentals and bearish technicals.
EXPO shows bullish fundamentals based on deterministic rules. Financial strength is strong (F-Score 9/9). Key strengths include strong valuation and growth metrics. Price trades at a 60.8% premium to fair value estimate ($41.50), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
AERO vs EXPO: Head-to-Head Comparison
This page compares Grupo Aeromexico, S.A.B. de C.V (AERO) and Exponent, Inc. (EXPO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.